ESG
How a healthcare partnership is steering environmental impact beyond plastics
On World Environment Day 2025, the theme Beat Plastic Pollution lands with particular weight in the healthcare sector – an […]
MoreESG
Unpacking the plastic pandemic: From policy gaps to practical solutions in healthcare
What happens when the very systems built to protect our health contribute to one of the planet’s most pressing environmental […]
MoreESG
Cardinal Health sets new benchmark in sustainability
In an era where sustainability has become a corporate buzzword, Jane Crowe, Managing Director of Cardinal Health ANZ, is pushing […]
MoreESG
Experts convene to tackle the growing toll of climate change on health and healthcare system
Environmental health experts are gathering today at the Australian Medical Association (AMA) in Canberra to address the growing health threats […]
MoreESG
Boehringer Ingelheim sets sustainability benchmark in NZ
Boehringer Ingelheim’s Auckland office has achieved a milestone in sustainability, earning the prestigious 6 Green Star Interiors certification from the […]
MoreESG
Pfizer stands firm with First Nations amidst stalled progress on Closing the Gap
Pfizer Australia launched its Innovate Reconciliation Action Plan (RAP) today, building on the learnings from its Reflect RAP and reaffirming […]
MoreESG
Celebrating unsung heroes: Gilead partners to shine a light on stigma and inequity
The National Association of People with HIV Australia (NAPWHA) and Gilead Sciences Australia have announced the recipients of the 2024 […]
MoreESG
Edwards Lifesciences VP challenges us to ‘dream bigger’ for underserved communities
Social Impact: Edwards Lifesciences ANZ held its annual Foundation Grants Day, an event that brought to life the company’s commitment […]
MoreESG
Surgeons lead push for $1.5 million hospital sustainability project
ESG: Australia’s healthcare sector contributes 7% of the country’s total emissions. The Royal Australasian College of Surgeons (RACS) has joined […]
MoreESG
Bayer launches nation’s first interactive garden, shaped as the female reproductive system
Social Impact: Bayer has unveiled a unique initiative aimed at prioritising women’s health: Australia’s first Lady Garden, located in Toowoomba’s […]
MoreRecent Posts in Pharma, MedTech & Biotech
Philips remote monitoring cuts hospital costs and ICU time by 69%
August 1, 2025
in News - MedTech & Diagnostics
VB Spine breaks ground in ANZ, Takes over Stryker’s spinal implants business
August 1, 2025
in News - MedTech & Diagnostics
New therapy PBS listed in advanced Parkinson’s disease
August 1, 2025
in News - Pharmaceuticals
PBS adds first ustekinumab and omalizumab biosimilars in inflammatory and allergic conditions
August 1, 2025
in News - Pharmaceuticals
November PBAC agenda unveiled amid tensions over tariff risks
July 31, 2025
in News - Pharmaceuticals
Promises, pitfalls and pressure points: Stakeholders weigh in on government’s AI healthcare report
July 31, 2025
in News - MedTech & Diagnostics
MSAC to consider funding for first TGA-approved TTVR device
July 31, 2025
in News - MedTech & Diagnostics
The triple squeeze on leaders and a messy middle: New future of work report
July 30, 2025
in Leadership & Management
Follow Us
Partner with us
News - MedTech & Diagnostics
Philips remote monitoring cuts hospital costs and ICU time by 69%
An innovative remote patient monitoring model has significantly improved post-operative care for patients, cutting ICU hours by 69% and saving […]
MoreNews - MedTech & Diagnostics
VB Spine breaks ground in ANZ, Takes over Stryker’s spinal implants business
VB Spine has officially taken the reins of Stryker’s spinal implants business in Australia and New Zealand. The transition builds […]
MoreNews - Pharmaceuticals
New therapy PBS listed in advanced Parkinson’s disease
A new therapeutic option for advanced Parkinson’s disease, Vyalev (foslevodopa with foscarbidopa), is now listed on the Pharmaceutical Benefits Scheme […]
MoreNews - Pharmaceuticals
PBS adds first ustekinumab and omalizumab biosimilars in inflammatory and allergic conditions
From 1 August 2025, two new biosimilars – SteQeyma (ustekinumab) and Omlyclo (omalizumab) – have been listed on the Pharmaceutical […]
More